Other

Amgen buys Micromet for anti-leukemia drug

Biotech giant Amgen said Thursday it was buying the German-American cancer research firm Micromet, giving it access to Micromet's promising leukemia therapy.

Alzheimer's disease & dementia

Medicare limits coverage of $28,000-a-year Alzheimer's drug

Medicare said Tuesday it will limit coverage of a $28,000-a-year Alzheimer's drug whose benefits have been widely questioned, a major development in the nation's tug-of-war over the fair value of new medicines that offer ...

Cardiology

One man's journey back from stroke at 52

(HealthDay)—Price Woodward was the picture of health at age 52. He lived an active lifestyle and ran marathons. He was definitely not the type of person you'd expect to have a stroke.

Medications

How new model boosts supply and lowers prices for generic drugs

Civica Rx, a not-for profit drug manufacturer founded by seven US health systems and three philanthropic organizations, increased supply security and lowered cost on aggregate for 20 drug products, according to the first ...

Medical economics

COVID-19: Governments must stop vaccine cost secrecy

Globally affordable COVID-19 vaccines will not be accessible until governments stop allowing vaccine companies to keep their manufacturing costs secret, according to a new paper published by the Journal of the Royal Society ...

Medications

CVS generic competitor to EpiPen, sold at a 6th the price

CVS is now selling a rival, generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated before Congress because of its soaring cost to ...

page 12 from 40